Marc D. Beer is CEO at Aegerion Pharmaceuticals, Inc. (AEGR). They have made 13 open-market trades across 3 companies since 2010, most recently 2026-08-11.
CIK 0001314575
12 open-market purchases totalling $6.3M since 2010, against 1 sale. Across 11 scored buys the stock is down 1.1% at ninety days, and 2.4 points behind the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BTMD | 239,744 | $265K |
| AEGR | 78,631 | $155K |
| NERV | 25,000 | $59K |
| VIAC | 700,000 | — |
| Total | $478K |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 0% | 9% |
| Avg Move | -21.0% | -6.6% | -1.1% |
| Alpha | -16.5% | -6.2% | -2.4% |
| Scored | 12 | 12 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BTMD | BUY | 2026-08-10 | 2026-08-12 | $1.53 | $202K | +1.6% | -13.2% | — |
| BTMD | BUY | 2025-03-17 | 2025-03-18 | $3.87 | $834K | -22.8% | -24.8% | -9.3% |
| BTMD | SELL | 2023-01-09 | 2023-01-10 | $3.00 | $2.6M | +0.3% | +33.5% | +55.1% |
| NERV | BUY | 2017-03-17 | 2017-03-21 | $8.12 | $406K | +6.6% | -7.9% | +30.3% |
| AEGR | BUY | 2014-07-31 | 2014-07-31 | $33.65 | $337K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2014-06-03 | 2014-06-04 | $30.12 | $301K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2014-05-27 | 2014-05-27 | $31.59 | $316K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2014-05-20 | 2014-05-21 | $30.53 | $305K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2014-05-08 | 2014-05-08 | $35.31 | $1.1M | -26.4% | -3.7% | -3.7% |
| AEGR | SELL · 10b5-1 | 2013-10-30 | 2013-10-31 | $87.79 | $3.5M | -26.4% | -3.7% | -3.7% |
| AEGR | SELL · 10b5-1 | 2013-08-15 | 2013-08-16 | $88.54 | $5.3M | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2012-03-29 | 2012-03-30 | $13.74 | $14K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2012-03-22 | 2012-03-23 | $13.96 | $14K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2011-09-01 | 2011-09-06 | $14.75 | $100K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2011-08-09 | 2011-08-10 | $11.95 | $120K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2011-08-01 | 2011-08-03 | $15.74 | $100K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2011-06-29 | 2011-06-29 | $15.50 | $1000K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2011-06-01 | 2011-06-03 | $18.70 | $100K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2011-04-04 | 2011-04-05 | $16.73 | $100K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2010-12-15 | 2010-12-17 | $12.33 | $2K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2010-10-27 | 2010-10-27 | $9.50 | $1000K | -26.4% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.